Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
Sign Up to like & getrecommendations! Published in 2023 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12224
Abstract: Abstract Continuous subcutaneous (SubQ) treprostinil is an effective therapy for pediatric patients diagnosed with pulmonary hypertension (PH). To date, the clinical characteristics and factors associated with failure to tolerate this therapy have not been described.… read more here.
Keywords: failure tolerate; continuous subcutaneous; subq treprostinil; treprostinil ... See more keywords